Down Syndrome and Organelle Dysfunction: Mitochondria, Lysosomes, and ER
Genetic Basis
Trisomy 21 → 1.5× gene dosage for ~300 chromosome 21 genes → proteomic imbalance affecting multiple organelles.
Mitochondrial Dysfunction
- Key genes: SOD1 (oxidative stress), APP (amyloid), DYRK1A (mitochondrial dynamics)
- Consequences: ↓ ATP production, ↑ ROS, ↓ membrane potential, fragmented morphology
- Clinical correlates: Hypotonia, fatigue, early aging, Alzheimer's-like neuropathology by 40s
Lysosomal Dysfunction
- Genes: APP (β-secretase substrate), CTSB (cathepsin B)
- Consequences: Impaired autophagy, lipofuscin accumulation, defective waste clearance
- Clinical: ↑ infection susceptibility, neuronal storage-like features
Endoplasmic Reticulum Stress
- Genes: DYRK1A, RCAN1 (calcineurin inhibitor)
- Consequences: Unfolded protein response (UPR) chronic activation → apoptosis
- Clinical: Impaired protein folding, insulin secretion defects, immune dysfunction
Therapeutic Implications
- Antioxidants (mitochondrial-targeted: MitoQ, SkQ1) — experimental
- Autophagy enhancers (rapamycin analogs) — preclinical
- DYRK1A inhibitors — clinical trials for cognitive enhancement
- Supportive: thyroid screening, cardiac monitoring, early intervention therapies
Neurological Disorders - Related Articles
- \"Brain Leakage\" Is a Myth—But Head Pain Is Real: When to See a Doctor
- Parkinson's Disease: A Progressive Neurological Disorder
- Understanding and Managing Reflex Sympathetic Dystrophy (RSD)
- Understanding and Supporting Individuals with Paranoid Thoughts
- Understanding Unresponsive Seizures (Status Epilepticus): Causes & Symptoms
- Understanding Alternative Therapies for Motor Neuron Diseases
- How Circulatory System Disorders Affect Other Body Systems